[Immunomodulating effects of indomethacin in breast cancer].
Polevaia
E B
EB
Chikvashvili
B Sh
BSh
Kupin
V I
VI
Letiagin
V P
VP
D000276:Adjuvants, Immunologic; D000328:Adult; D000917:Antibody Formation / Q000187:drug effects; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D001943:Breast Neoplasms / Q000188:drug therapy* / Q000276:immunology; D003520:Cyclophosphamide / Q000008:administration & dosage; D004317:Doxorubicin / Q000008:administration & dosage; D004341:Drug Evaluation; D005260:Female; D005472:Fluorouracil / Q000008:administration & dosage; D006801:Humans; D007111:Immunity, Cellular / Q000187:drug effects; D007213:Indomethacin / Q000627:therapeutic use*; D008727:Methotrexate / Q000008:administration & dosage; D008875:Middle Aged; D011300:Preoperative Care; D014750:Vincristine / Q000008:administration & dosage
D000276:Adjuvants, Immunologic; D014750:Vincristine; D004317:Doxorubicin; D003520:Cyclophosphamide; D005472:Fluorouracil; D007213:Indomethacin; D008727:Methotrexate
Immunomoduliruiushchie éffekty indometatsina pri rake molochnoĭ zhelezy.